This article was originally published in The Gray Sheet
Disposable medical glove maker submits appeal of Nasdaq delisting notice, to be effective May 11. The firm did not sustain compliance with Nasdaq's minimum bid requirement of $1.00 within a 90-day grace period set forth in a Feb. 2 notice. Once Nasdaq receives WRP's request for a hearing, the request "will automatically defer" the delisting until Nasdaq's hearing panel makes a ruling, WRP explains. Itasca, Illinois-based WRP "will be presenting its business plan to the hearing panel and will seek to put in place steps to avoid delisting prior to any delisting of its shares"
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.